Sarabia, Naomi A.
HRN: 26-09-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/25/2024
11/01/2024
IV
1.5gm
Q6h
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes